Ketolong-Darnitsa
Release form:
Release form:
Ketorolac tromethamine is a nonnarcotic analgesic. It is a non-steroidal anti-inflammatory drug (hereinafter referred to as NSAID) that exhibits anti-inflammatory and weak antipyretic activity.
Short-term treatment of moderate pain, including postoperative pain.
Take the tablet during or after meals. The medicine is recommended for short-term use only (up to 5 days).
In order to minimise adverse effects, the medicine should be administered at the lowest effective dose for the shortest period of time required to control the symptoms. Normovolemia must be achieved before treatment.
Ketolong-Darnitsa® should be administered by 10 mg every 4-6 hours as needed. The medicine is not recommended for use at doses exceeding 40 mg per day. Opioid analgesics (e.g. morphine, pethidine) can be used in parallel, ketorolac does not affect the binding of opioid medicines and does not exacerbate respiratory depression or sedative effects of opioids. For patients that receive ketorolac parenterally and are prescribed ketorolac tablets orally, the total combined daily dose should not exceed 90 mg (60 mg for the elderly, patients with impaired renal function, and patients of less than 50 kg body weight), while oral medicine dosage should not exceed 40 mg per day when the used dosage form is changed. Patients should be switched to oral medicine administration as soon as possible.